White Manna Capital Partners – Important Disclaimer

White Manna Capital Partners, LP ("WMCP") is a private investment management firm that advises certain private investment funds and qualified institutional clients. WMCP does not offer investment advisory services to the general public.

The information presented on this website and within WMCP publications is intended solely for informational and educational purposes for audiences such as prospective talent, industry professionals, counterparties, researchers, and members of the media. Nothing contained herein constitutes, or should be construed as, an offer to sell or the solicitation of an offer to purchase any securities, investment products, or advisory services. Any such offer, if made, will be made only through formal offering materials and to persons who satisfy eligibility requirements under applicable securities laws.

This website does not contain sufficient information to form the basis of an investment decision. Any investment in a WMCP-managed fund involves significant risks and is available only to a limited group of eligible investors.

Certain content provided by third parties may be included. WMCP does not guarantee and has not independently verified the accuracy, completeness, or timeliness of such third-party materials, and such information may omit important context.

All content on this website is the proprietary intellectual property of WMCP or its licensors. You may not copy, modify, distribute, publish, display, perform, transmit, or use this content for any commercial purpose without WMCP's prior written consent.

By continuing to access this website or related WMCP materials, you acknowledge and agree that:

  • You are accessing this information only for general informational purposes;
  • You understand WMCP's investment offerings are not open to the general public; and
  • You will not treat any information here as a basis for making an investment decision.

Advancing Perspectives in Biotech &
Healthcare Investing

Research & Insights

At White Manna Capital Partners, we believe that superior investment outcomes are built on evidence-driven insights, deep therapeutic expertise, and a disciplined understanding of where scientific innovation meets financial markets.

Our Research & Insights library features perspectives from our investment team on trends shaping the global biopharmaceutical and healthcare industries—including analysis of breakthrough therapies, regulatory catalysts, capital flow dynamics, AI-driven drug development, and emerging market opportunities.

Whether you are an industry stakeholder, institutional investor, healthcare leader, or academic partner, our goal is to make complex science and market behavior more accessible, actionable, and forward-looking.

Featured Publications

White Paper

"Make America Healthy Again"

by Michael Jeong, MD

A strategic perspective on how the Make America Healthy Again initiative could impact investment strategies in the life sciences.